Stocksigma LogoStocksigma Logo

Piramal Pharma Receives GST Demand and Penalty Order Totaling ₹8.12 Crore

Piramal Pharma received an Order-in-Original from CGST Mumbai East confirming an Input Tax Credit demand of Rs

Piramal Pharma Receives GST Demand and Penalty Order Totaling ₹8.12 Crore

Piramal Pharma Ltd · Others (Uncategorized) · 29 Sept 2026, 4:29 pm

Piramal Pharma Receives GST Demand and Penalty Order Totaling ₹8.12 Crore Piramal Pharma received an Order-in-Original from CGST Mumbai East confirming an Input Tax Credit demand of Rs. 4.06 cr along with applicable interest and an equivalent penalty of Rs. 4.06 cr for FY'21 to FY'23. The tax dispute pertains to post-demerger transitional ITC, ISD registrations, and cross-charged expenses from Piramal Enterprises. The company intends to appeal the order before appellate authorities within prescribed timelines and expects no material impact on its financials or operations.

Original exchange filing (PDF)

More announcements from Piramal Pharma Ltd

All Piramal Pharma Ltd announcements